Status:
COMPLETED
Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers
Lead Sponsor:
Dermira, Inc.
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is assess the safety and tolerability of lemuteporfin topical solution (LTS) with exposure to red light (PDT), when applied to the backs of healthy volunteers.
Detailed Description
This is an open-label, safety study in healthy volunteers. Two cohorts, of 6 subjects each, will be enrolled (total subjects = 12). Each subject will have test areas identified on the back and receive...
Eligibility Criteria
Inclusion
- Healthy adults 18 years of age or older
- Fitzpatrick skin types I-IV
Exclusion
- Current pregnancy or lactation.
- Presence of severe facial acne, acne fulminans or conglobata, or nodulocystic acne.
- Poor skin condition on the back, including erythema, dryness, sunburn, dermatological malignancies, infections, cuts, abrasions, tattoo, excess of hair or any other skin condition
- Subjects who have used any agents known to produce significant photosensitivity reactions (tetracyclines, phenothiazines, trimethoprim, etc.) within 2 weeks of Day 1 or 5 half-lives, whichever is longer.
- Subjects who have used any medicated topical therapy on the back within 3 days of Day 1.
- Chronic treatment with low dose aspirin, a non-steroidal anti inflammatory drug (NSAID), or an anticoagulant regimen such as warfarin (Coumadin).
- Abnormal findings on screening ECG deemed clinically significant by the Investigator.
- Active participation in an experimental therapy study or experimental therapy within 30 days of Day 1.
- Screening clinical chemistry or hematology laboratory value that is considered clinically significant, in the opinion of the Investigator.
- Subjects who are a poor medical risk because of other systemic diseases or active uncontrolled infections.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01830764
Start Date
April 1 2013
End Date
June 1 2013
Last Update
July 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TKL Research Inc (Research Clinics Division)
Paramus, New Jersey, United States, 07652